1412 related articles for article (PubMed ID: 30551375)
21. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
Lau S; Fei J; Liu H; Chen W; Liu R
J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
[TBL] [Abstract][Full Text] [Related]
22. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
23. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
24. Microneedles and their applications.
Sachdeva V; Banga AK
Recent Pat Drug Deliv Formul; 2011 May; 5(2):95-132. PubMed ID: 21453248
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
26. Microneedle penetration and injection past the stratum corneum in humans.
Sivamani RK; Stoeber B; Liepmann D; Maibach HI
J Dermatolog Treat; 2009; 20(3):156-9. PubMed ID: 19016065
[TBL] [Abstract][Full Text] [Related]
27. Nanomaterial and advanced technologies in transdermal drug delivery.
Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847
[TBL] [Abstract][Full Text] [Related]
28. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
29. Macromolecular delivery into skin using a hollow microneedle.
Wonglertnirant N; Todo H; Opanasopit P; Ngawhirunpat T; Sugibayashi K
Biol Pharm Bull; 2010; 33(12):1988-93. PubMed ID: 21139238
[TBL] [Abstract][Full Text] [Related]
30. Microneedle-based drug delivery systems for transdermal route.
Pierre MB; Rossetti FC
Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
[TBL] [Abstract][Full Text] [Related]
31. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
[TBL] [Abstract][Full Text] [Related]
32. Transdermal Microneedles-A Materials Perspective.
Ali R; Mehta P; Arshad MS; Kucuk I; Chang MW; Ahmad Z
AAPS PharmSciTech; 2019 Dec; 21(1):12. PubMed ID: 31807980
[TBL] [Abstract][Full Text] [Related]
33. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
34. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
35. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
[TBL] [Abstract][Full Text] [Related]
36. Precise microinjection into skin using hollow microneedles.
Wang PM; Cornwell M; Hill J; Prausnitz MR
J Invest Dermatol; 2006 May; 126(5):1080-7. PubMed ID: 16484988
[TBL] [Abstract][Full Text] [Related]
37. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues.
Rzhevskiy AS; Singh TRR; Donnelly RF; Anissimov YG
J Control Release; 2018 Jan; 270():184-202. PubMed ID: 29203415
[TBL] [Abstract][Full Text] [Related]
38. Preparation, properties and challenges of the microneedles-based insulin delivery system.
Chen X; Wang L; Yu H; Li C; Feng J; Haq F; Khan A; Khan RU
J Control Release; 2018 Oct; 288():173-188. PubMed ID: 30189223
[TBL] [Abstract][Full Text] [Related]
39. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
[TBL] [Abstract][Full Text] [Related]
40. Rapidly separating microneedles for transdermal drug delivery.
Zhu DD; Wang QL; Liu XB; Guo XD
Acta Biomater; 2016 Sep; 41():312-9. PubMed ID: 27265152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
